Parkwalk News

Latest Articles

• Semarion Secures $3.8 Million in New Funding to Scale Next-Generation Cell Assay Platform

  Published: Mar 31, 2026

  Section: Health

  University of Cambridge spin-out Semarion has raised $3.8 million to accelerate the commercial expansion and manufacturing of its SemaCyte® cell assay technology. The investment, l...